BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Qi X, Han G, Fan D. Management of portal vein thrombosis in liver cirrhosis. Nat Rev Gastroenterol Hepatol 2014;11:435-46. [PMID: 24686266 DOI: 10.1038/nrgastro.2014.36] [Cited by in Crossref: 99] [Cited by in F6Publishing: 107] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhou Y, Zhuang Z, Yu T, Zhang W, Ma J, Yu J, Yan Z, Luo J. Long-term efficacy and safety of anticoagulant for cavernous transformation of the portal vein cirrhotic patient with extrahepatic portal vein obstruction. Thromb J 2023;21:6. [PMID: 36631860 DOI: 10.1186/s12959-023-00449-8] [Reference Citation Analysis]
2 Ouyang R, Li H, Tan W, Wang X, Zheng X, Huang Y, Meng Z, Gao Y, Qian Z, Liu F, Lu X, Shi Y, Shang J, Liu J, Deng G, Zheng Y, Yan H, Jiang X, Zhang Y, Qiao L, Zhou Y, Hou Y, Xiong Y, Chen J, Luo S, Gao N, Ji L, Li J, Zheng R, Ren H, Wang H, Zhong G, Li B, Chen J. Portal vein thrombosis compromises the performance of MELD and MELD-Na scores in patients with cirrhosis. J Gastroenterol Hepatol 2023;38:129-37. [PMID: 36345143 DOI: 10.1111/jgh.16053] [Reference Citation Analysis]
3 Cong Y, Baimanov D, Zhou Y, Chen C, Wang L. Penetration and translocation of functional inorganic nanomaterials into biological barriers. Adv Drug Deliv Rev 2022;191:114615. [PMID: 36356929 DOI: 10.1016/j.addr.2022.114615] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Guo D, Fan L, Le Q, Huang C. Transjugular intrahepatic portosystemic shunt for the prevention of rebleeding in patients with cirrhosis and portal vein thrombosis: Systematic review and meta-analysis. Front Pharmacol 2022;13:968988. [DOI: 10.3389/fphar.2022.968988] [Reference Citation Analysis]
5 Li Z, Xu WT, Xu XB, Qi XS. Heparins for prevention and treatment of venous thromboembolism in cirrhosis: Research advances. Shijie Huaren Xiaohua Zazhi 2022; 30(9): 381-386 [DOI: 10.11569/wcjd.v30.i9.381] [Reference Citation Analysis]
6 Jin S, Hong L, Fakhriravari A. The Role of Vitamin K in Cirrhosis: Do Pharmaco-K-Netics Matter? Gastrointestinal Disorders 2022;4:15-21. [DOI: 10.3390/gidisord4010003] [Reference Citation Analysis]
7 Yokoyama S, Ishizu Y, Honda T, Imai N, Ito T, Yamamoto K, Tsuzuki T, Ishigami M. Absence of large portal collateral vessels is associated with spontaneous improvement of cirrhotic portal vein thrombosis. Hepatol Res 2022;52:199-209. [PMID: 34687492 DOI: 10.1111/hepr.13725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Lv Y, Han G. Special Settings: Acute Variceal Bleeding and Portal Vein Thrombosis in Cirrhosis. Portal Hypertension VII 2022. [DOI: 10.1007/978-3-031-08552-9_45] [Reference Citation Analysis]
9 Gu W, Hortlik H, Erasmus HP, Schaaf L, Zeleke Y, Uschner FE, Ferstl P, Schulz M, Peiffer KH, Queck A, Sauerbruch T, Brol MJ, Rohde G, Sanchez C, Moreau R, Arroyo V, Zeuzem S, Welsch C, Trebicka J. Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018). Lancet Reg Health Eur 2022;12:100240. [PMID: 34901909 DOI: 10.1016/j.lanepe.2021.100240] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
10 Xu S, Guo X, Xu X, Wang L, Tacke F, Primignani M, He Y, Yin Y, Yi F, Qi X. Natural history and predictors associated with the evolution of portal venous system thrombosis in liver cirrhosis. Eur J Gastroenterol Hepatol 2021;33:e423-30. [PMID: 33731591 DOI: 10.1097/MEG.0000000000002123] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
11 Ronca V, Barabino M, Santambrogio R, Opocher E, Hodson J, Bertolini E, Birocchi S, Piccolo G, Battezzati P, Cattaneo M, Podda GM. Impact of Platelet Count on Perioperative Bleeding in Patients With Cirrhosis Undergoing Surgical Treatments of Liver Cancer. Hepatol Commun 2021. [PMID: 34716696 DOI: 10.1002/hep4.1806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Sakamoto Y, Sato K, Ishikawa C, Kagawa Y, Nakayama T, Sakai M. Long-term follow-up of portal vein thrombosis in an American Cocker Spaniel with lobular dissecting hepatitis: a case report. BMC Vet Res 2021;17:319. [PMID: 34592989 DOI: 10.1186/s12917-021-03017-2] [Reference Citation Analysis]
13 Shi Q, Xiong K, Ding B, Ye X. Clinical characteristics of cirrhosis patients with umbilical vein recanalization: A retrospective analysis. Medicine (Baltimore) 2021;100:e26774. [PMID: 34477116 DOI: 10.1097/MD.0000000000026774] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhou T, Sun X, Zhou T, Li Y, Chen X, Cheng B, Gao Y. Efficacy and Safety of Nadroparin Calcium-Warfarin Sequential Anticoagulation in Portal Vein Thrombosis in Cirrhotic Patients: A Randomized Controlled Trial. Clin Transl Gastroenterol 2020;11:e00228. [PMID: 32858573 DOI: 10.14309/ctg.0000000000000228] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
15 Lv Y, Bai W, Li K, Wang Z, Guo W, Luo B, Wang J, Wang Q, Wang E, Xia D, Li X, Yuan J, Han N, Niu J, Yin Z, Fan D, Han G. Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study. Am J Gastroenterol 2021;116:1447-64. [PMID: 33630766 DOI: 10.14309/ajg.0000000000001194] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
16 Yuan HL, Wang M, Chu WW, Li FX, Lu JJ, Li Y. Nomogram Model for Prediction of Portal Vein Thrombosis in Patients with Liver Cirrhosis After Splenectomy: A Retrospective Analysis of 2 Independent Cohorts. Med Sci Monit 2021;27:e929844. [PMID: 34075015 DOI: 10.12659/MSM.929844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Xian J, Tang Y, Shao H, Wang X, Zhang M, Xing T. Effect of portal vein thrombosis on the prognosis of patients with cirrhosis without a liver transplant: A systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e25439. [PMID: 33879676 DOI: 10.1097/MD.0000000000025439] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Sun XY, Wang GC, Wang J, Huang GJ, Zhang CQ. Transjugular intrahepatic portosystemic shunt is effective in patients with chronic portal vein thrombosis and variceal bleeding. Hepatobiliary Pancreat Dis Int 2021;20:128-36. [PMID: 33455864 DOI: 10.1016/j.hbpd.2020.12.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Wu Y, Li H, Zhang T, Bai Z, Xu X, Levi Sandri GB, Wang L, Qi X. Splanchnic Vein Thrombosis in Liver Cirrhosis After Splenectomy or Splenic Artery Embolization: A Systematic Review and Meta-Analysis. Adv Ther 2021;38:1904-30. [PMID: 33687650 DOI: 10.1007/s12325-021-01652-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
20 Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai). J Dig Dis 2021;22:176-86. [PMID: 33470535 DOI: 10.1111/1751-2980.12970] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
21 Wu WY, Kong DR. Advances in diagnosis and treatment of portal venous thrombosis. Shijie Huaren Xiaohua Zazhi 2021; 29(4): 165-173 [DOI: 10.11569/wcjd.v29.i4.165] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Gao Y, Liu H, Tang F, Zhang X, Li F, Ye Q, Yuan H, Lv H, Han T. Efficacy and safety of anticoagulants in liver cirrhosis patients with portal vein thrombosis: A meta-analysis. Clin Res Hepatol Gastroenterol 2021;45:101649. [PMID: 33601064 DOI: 10.1016/j.clinre.2021.101649] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
23 Ueda J, Mamada Y, Taniai N, Yoshioka M, Hirakata A, Kawano Y, Shimizu T, Kanda T, Takata H, Kondo R, Kaneya Y, Aoki Y, Yoshida H. Massage of the Hepatoduodenal Ligament Recovers Portal Vein Flow Immediately After the Pringle Maneuver in Hepatectomy. World J Surg 2020;44:3086-92. [PMID: 32394011 DOI: 10.1007/s00268-020-05570-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 Wang L, Guo X, Xu X, Philips CA, Primignani M, Mendez-Sanchez N, Li Q, Zheng K, Qi X. Association of portal venous system thrombosis with endoscopic variceal treatment: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2021;32:125-31. [PMID: 32501878 DOI: 10.1097/MEG.0000000000001774] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Durand F, Dokmak S, Roux O, Francoz C. Liver Transplantation in the Setting of Non-malignant Portal Vein Thrombosis. Portal Vein Thrombosis 2021. [DOI: 10.1007/978-981-33-6538-4_10] [Reference Citation Analysis]
26 Takatori H, Hayashi T, Nakagawa H, Kaneko S. Impact of Non-malignant Portal Vein Thrombosis on Outcomes of Liver Cirrhosis. Portal Vein Thrombosis 2021. [DOI: 10.1007/978-981-33-6538-4_6] [Reference Citation Analysis]
27 Noronha Ferreira C. Anticoagulation for Nontumoral Portal Vein Thrombosis. Portal Vein Thrombosis 2021. [DOI: 10.1007/978-981-33-6538-4_7] [Reference Citation Analysis]
28 Sherman C, Syed S, Gardner J, Yao FY. CON: Portal Vein Thrombosis Does Not Impact Liver Transplantation Outcomes. Clin Liver Dis (Hoboken) 2020;16:132. [PMID: 33163163 DOI: 10.1002/cld.939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Lin H, Bai Z, Guo X, Qi X. Association between nonalcoholic fatty liver disease and portal vein thrombosis: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2020;32:1405-6. [PMID: 32858662 DOI: 10.1097/MEG.0000000000001689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Zhang Y, Xu BY, Wang XB, Zheng X, Huang Y, Chen J, Meng ZJ, Gao YH, Qian ZP, Liu F, Lu XB, Shi Y, Shang J, Li H, Wang SY, Yin S, Sun SN, Hou YX, Xiong Y, Chen J, Li BL, Lei Q, Gao N, Ji LJ, Li J, Jie FR, Zhao RH, Liu JP, Lin TF, Chen LY, Tan WT, Zhang Q, Zou CC, Huang ZB, Jiang XH, Luo S, Liu CY, Zhang YY, Li T, Ren HT, Wang SJ, Deng GH, Xiong SE, Liu XX, Wang C, Yuan W, Gu WY, Qiao L, Wang TY, Wu DD, Dong FC, Li H, Hua J. Prevalence and Clinical Significance of Portal Vein Thrombosis in Patients With Cirrhosis and Acute Decompensation. Clin Gastroenterol Hepatol 2020;18:2564-2572.e1. [PMID: 32109631 DOI: 10.1016/j.cgh.2020.02.037] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 10.7] [Reference Citation Analysis]
31 Zhou Y, Zhang W, Zhang Z, Luo J, Gu J, Liu Q, Ma J, Yan Z, Chen S, Wang J. PTFE-covered TIPS is an effective treatment for secondary preventing variceal rebleeding in cirrhotic patients with high risks. Eur J Gastroenterol Hepatol 2020;32:1235-43. [PMID: 32744824 DOI: 10.1097/MEG.0000000000001686] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
32 Allaire M, Walter A, Sutter O, Nahon P, Ganne-carrié N, Amathieu R, Nault J. TIPS for management of portal-hypertension-related complications in patients with cirrhosis. Clinics and Research in Hepatology and Gastroenterology 2020;44:249-63. [DOI: 10.1016/j.clinre.2019.09.003] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
33 Khoury T, Massarwa M, Hazou W, Daher S, Hakimian D, Benson AA, Ashqar T, Mahamid M, Yaari S. Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients. J Gastrointest Cancer 2019;50:759-62. [PMID: 30043228 DOI: 10.1007/s12029-018-0149-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
34 Liu J, Zhou C, Shi Q, Ma J, Ye T, Zheng C, Feng G, Xiong B. Exploration of interventional therapy strategy for portal vein occlusion: a case series study. Eur J Gastroenterol Hepatol 2020;32:507-16. [PMID: 31658174 DOI: 10.1097/MEG.0000000000001586] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
35 Xu X, Xu S, Primignani M, De Stefano V, He Y, Yi F, Guo X, Valla D, Qi X. Nonselective β-Blockers May Progress the Thrombosis of Portal Venous System in Cirrhotic Patients: A Retrospective Observational Study. Adv Ther 2020;37:1452-63. [PMID: 32076942 DOI: 10.1007/s12325-020-01250-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
36 Zhang L, Huan H, Tong H, Wei B, Wang Z, Liu C, Wu H. Warfarin prevented de novo portal vein thrombosis after transjugular intrahepatic portosystemic shunt: A retrospective study. Medicine (Baltimore) 2020;99:e18737. [PMID: 31914090 DOI: 10.1097/MD.0000000000018737] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
37 Zheng K, Yoshida EM, Tacke F, Li Y, Guo X, Qi X. Risk of Stroke in Liver Cirrhosis: A Systematic Review and Meta-Analysis. J Clin Gastroenterol 2020;54:96-105. [PMID: 30882537 DOI: 10.1097/MCG.0000000000001201] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
38 Hayashi T, Takatori H, Horii R, Nio K, Terashima T, Iida N, Kitahara M, Shimakami T, Arai K, Kitamura K, Kawaguchi K, Yamashita T, Sakai Y, Yamashita T, Mizukoshi E, Honda M, Toyama T, Okumura K, Kozaka K, Kaneko S. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients. BMC Gastroenterol 2019;19:217. [PMID: 31842768 DOI: 10.1186/s12876-019-1140-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
39 Huang X, Thansamay S, Yang K, Luo T, Chen S. Measurement of Exhaled Nitric Oxide in Cirrhotic Patients with Esophageal and Gastric Varices. Biomed Res Int 2019;2019:9673162. [PMID: 31781658 DOI: 10.1155/2019/9673162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Xu X, Guo X, Wang R, Wang L, Li Q, Yi F, Li H, Qi X. Low-molecular-weight heparin followed by rivaroxaban for acute occlusive portomesenteric vein thrombosis in a cirrhotic patient treated with multiple endoscopic variceal procedures. Ann Hepatol 2020;19:573-7. [PMID: 31521463 DOI: 10.1016/j.aohep.2019.08.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
41 Du ZQ, Zhao JZ, Dong J, Bi JB, Ren YF, Zhang J, Khalid B, Wu Z, Lv Y, Zhang XF, Wu RQ. Effect of low-dose aspirin administration on long-term survival of cirrhotic patients after splenectomy: A retrospective single-center study. World J Gastroenterol 2019; 25(28): 3798-3807 [PMID: 31391774 DOI: 10.3748/wjg.v25.i28.3798] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
42 Then EO, Are VS, Lopez-Luciano M, Bijjam R, Ofosu A, Culliford A, Gaduputi V. Elevated International Normalized Ratio: A Risk Factor for Portal Vein Thrombosis in Cirrhotic Patients. Gastroenterology Res 2019;12:135-40. [PMID: 31236154 DOI: 10.14740/gr1179] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
43 Xu X, Guo X, De Stefano V, Silva-Junior G, Goyal H, Bai Z, Zhao Q, Qi X. Nonselective beta-blockers and development of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis. Hepatol Int 2019;13:468-81. [PMID: 31175581 DOI: 10.1007/s12072-019-09951-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
44 Cui LB, Ren S, Xi YB, Zeng LL, Chen G, Liu K, Yu T, He C, Guo W, Yin Z, Wang Z, Niu J, Luo B, Hu D, Han G, Yin H. Motor Cortex Mapping in Patients With Hepatic Myelopathy After Transjugular Intrahepatic Portosystemic Shunt. Acad Radiol 2019;26:e38-46. [PMID: 30076082 DOI: 10.1016/j.acra.2018.06.013] [Reference Citation Analysis]
45 Li LN, Sun XY, Wang GC, Tian XG, Zhang MY, Jiang KT, Zhang CQ. Transjugular intrahepatic portosystemic shunt prevents rebleeding in cirrhotic patients having cavernous transformation of the portal vein without improving their survival. J Dig Dis 2019;20:89-96. [PMID: 30629804 DOI: 10.1111/1751-2980.12702] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
46 Lv Y, Qi X, He C, Wang Z, Yin Z, Niu J, Guo W, Bai W, Zhang H, Xie H, Yao L, Wang J, Li T, Wang Q, Chen H, Liu H, Wang E, Xia D, Luo B, Li X, Yuan J, Han N, Zhu Y, Xia J, Cai H, Yang Z, Wu K, Fan D, Han G; PVT-TIPS Study Group. Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial. Gut 2018;67:2156-68. [PMID: 28970291 DOI: 10.1136/gutjnl-2017-314634] [Cited by in Crossref: 88] [Cited by in F6Publishing: 88] [Article Influence: 17.6] [Reference Citation Analysis]
47 Zampino R, Lebano R, Coppola N, Macera M, Grandone A, Rinaldi L, De Sio I, Tufano A, Stornaiuolo G, Adinolfi LE, Durante-Mangoni E, Battista GG, Niglio A. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients. Saudi J Gastroenterol 2018;24:25-9. [PMID: 29451181 DOI: 10.4103/sjg.SJG_100_17] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
48 Zhang LH, Tong H, Wei B, Wu H, Tang CW. Transjugular Intrahepatic Portosystemic Shunt as the Treatment for Refractory Hepatic Hydrothorax with Portal Vein Thrombosis. Chin Med J (Engl) 2017;130:1999-2000. [PMID: 28776556 DOI: 10.4103/0366-6999.211887] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
49 Rao R, Grosel J. Acute portal vein thrombosis in a 59-year-old male with JAK2 V617F mutation. Radiol Case Rep 2018;13:1249-55. [PMID: 30258517 DOI: 10.1016/j.radcr.2018.08.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
50 Basili S, Pastori D, Raparelli V, Violi F. Anticoagulant therapy in patients with liver cirrhosis and portal vein thrombosis: insights for the clinician. Therap Adv Gastroenterol 2018;11:1756284818793561. [PMID: 30202445 DOI: 10.1177/1756284818793561] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
51 Lin W, Lu X, Fan F, Hu Y. Predictive Effect of Mean Platelet Volume in Patients with Portal Vein Thrombosis: A Meta-analysis of Case-control Studies. CURR MED SCI 2018;38:575-81. [DOI: 10.1007/s11596-018-1916-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
52 Stravitz RT. Algorithms for managing coagulation disorders in liver disease. Hepatol Int 2018;12:390-401. [PMID: 30066204 DOI: 10.1007/s12072-018-9886-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
53 Xue S, Wang P, Han H, Chen G. Portal Vein Thrombosis in Liver Cirrhosis. Management of Chronic Liver Diseases - Recent Advances 2018. [DOI: 10.5772/intechopen.76295] [Reference Citation Analysis]
54 Aggeletopoulou I, Konstantakis C, Manolakopoulos S, Triantos C. Role of band ligation for secondary prophylaxis of variceal bleeding. World J Gastroenterol 2018;24:2902-14. [PMID: 30018485 DOI: 10.3748/wjg.v24.i26.2902] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
55 Qi X, Guo X, Yoshida EM, Méndez-Sánchez N, De Stefano V, Tacke F, Mancuso A, Sugawara Y, Yang SS, Teschke R, Arora A, Valla DC. Transient portal vein thrombosis in liver cirrhosis. BMC Med 2018;16:83. [PMID: 29871683 DOI: 10.1186/s12916-018-1069-8] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 8.8] [Reference Citation Analysis]
56 Regnault D, d'Alteroche L, Nicolas C, Dujardin F, Ayoub J, Perarnau JM. Ten-year experience of transjugular intrahepatic portosystemic shunt for noncirrhotic portal hypertension. Eur J Gastroenterol Hepatol 2018;30:557-62. [PMID: 29324586 DOI: 10.1097/MEG.0000000000001067] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
57 Otani I, Oka S, Tanaka S, Tsuboi A, Kunihara S, Nagaoki Y, Aikata H, Chayama K. Clinical significance of small-bowel villous edema in patients with liver cirrhosis: A capsule endoscopy study. J Gastroenterol Hepatol 2018;33:825-30. [PMID: 29023961 DOI: 10.1111/jgh.14016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
58 Lombardo S, Espejo J, Pérez-montilla M, Zurera L, González-galilea Á. The keys to successful TIPS in patients with portal vein thrombosis and cavernous transformation. Radiología (English Edition) 2018;60:94-104. [DOI: 10.1016/j.rxeng.2018.02.001] [Reference Citation Analysis]
59 Regnault H, Emambux S, Lecomte T, Doat S, Dhooge M, Besson M, Dubreuil O, Moryoussef F, Silvain C, Bachet JB, Tougeron D. Clinical outcome of portal vein thrombosis in patients with digestive cancers: A large AGEO multicenter study. Dig Liver Dis 2018;50:285-90. [PMID: 29183764 DOI: 10.1016/j.dld.2017.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
60 Stravitz RT. Hematological Issues in Liver Disease. Hepatic Critical Care 2018. [DOI: 10.1007/978-3-319-66432-3_13] [Reference Citation Analysis]
61 Benson A, Oren R. The Liver in Pregnancy. Zakim and Boyer's Hepatology 2018. [DOI: 10.1016/b978-0-323-37591-7.00054-9] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
62 Saeian K, Kohli A, Ahn J. Portal Hypertensive Gastrointestinal Bleeding. Hepatic Critical Care 2018. [DOI: 10.1007/978-3-319-66432-3_10] [Reference Citation Analysis]
63 (Ryu Sugimoto) 杉龍, (Makoto Takaki) 髙誠, (Yujirou Nakayama) 中雄, (Tadashi Kikuchi) 菊忠, (Yasuhiro Gushima) 具泰, (Junichi Maehara) 前潤. 抗菌薬とアピキサバンの併用によって治療し得た化膿性血栓性門脈炎の1例(A case of pylephlebitis treated by antibiotics and apixaban). Nihon Kyukyu Igakukai Zasshi: Japanese Journal of Japanese Association for Acute Medicine 2017;28:910-914. [DOI: 10.1002/jja2.12237] [Reference Citation Analysis]
64 Qi X, De Stefano V, Guo X, Fan D. Thrombopoietin receptor agonists significantly increase the risk of portal vein thrombosis in liver diseases: Meta-analysis of RCTs. Thromb Haemost 2015;113:1378-80. [PMID: 25761530 DOI: 10.1160/TH14-10-0892] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
65 Lombardo S, Espejo JJ, Pérez-Montilla ME, Zurera LJ, González-Galilea Á. The keys to successful TIPS in patients with portal vein thrombosis and cavernous transformation. Radiologia (Engl Ed) 2018;60:94-104. [PMID: 29122309 DOI: 10.1016/j.rx.2017.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
66 Fujiyama S, Saitoh S, Kawamura Y, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Suzuki Y, Suzuki F, Arase Y, Ikeda K, Kumada H. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome. BMC Gastroenterol 2017;17:112. [PMID: 29070023 DOI: 10.1186/s12876-017-0668-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 4.5] [Reference Citation Analysis]
67 Qi X, Yoshida EM, Mendez-Sanchez N, Guo X. Rivaroxaban recanalized occlusive superior mesenteric vein thrombosis, but increased the risk of bleeding in a cirrhotic patient. Liver Int 2017;37:1574-5. [PMID: 28675619 DOI: 10.1111/liv.13511] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
68 Qi X, Wu C, Hou Y, Guo X. Portal cavernoma in a case of alcoholic liver disease with myeloproliferative neoplasm. Clin Exp Hepatol 2016;2:125-7. [PMID: 28856275 DOI: 10.5114/ceh.2016.61468] [Reference Citation Analysis]
69 Yan Y, Guan C, Du S, Zhu W, Ji Y, Su N, Mei X, He D, Lu Y, Zhang C, Xing XH. Effects of Enzymatically Depolymerized Low Molecular Weight Heparins on CCl4-Induced Liver Fibrosis. Front Pharmacol. 2017;8:514. [PMID: 28871223 DOI: 10.3389/fphar.2017.00514] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
70 Loudin M, Ahn J. Portal Vein Thrombosis in Cirrhosis. J Clin Gastroenterol 2017;51:579-85. [PMID: 28489645 DOI: 10.1097/MCG.0000000000000834] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
71 Dhaliwal A, Armstrong MJ, Tripathi D. Patient Selection for Transjugular Intrahepatic Portosystemic Stent Shunt (TIPSS) Insertion in Variceal Bleeding and Refractory Ascites. Curr Hepatology Rep 2017;16:241-9. [DOI: 10.1007/s11901-017-0361-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
72 Lv Y, He C, Wang Z, Guo W, Wang J, Bai W, Zhang L, Wang Q, Liu H, Luo B. Association of Nonmalignant Portal Vein Thrombosis and Outcomes after Transjugular Intrahepatic Portosystemic Shunt in Patients with Cirrhosis. Radiology. 2017;285:999-1010. [PMID: 28682164 DOI: 10.1148/radiol.2017162266] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
73 Kawaratani H, Fukui H, Yoshiji H. Treatment for cirrhotic ascites. Hepatol Res 2017;47:166-77. [PMID: 27363974 DOI: 10.1111/hepr.12769] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
74 Cheong JY. Anticoagulation in Patients with Liver Cirrhosis. Korean J Gastroenterol 2017;70:218. [DOI: 10.4166/kjg.2017.70.5.218] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
75 Wu X, Yao Z, Zhao L, Zhang Y, Cao M, Li T, Ding W, Liu Y, Deng R, Dong Z, Chen H, Novakovic VA, Bi Y, Kou J, Tian Y, Zhou J, Shi J. Phosphatidylserine on blood cells and endothelial cells contributes to the hypercoagulable state in cirrhosis. Liver Int 2016;36:1800-10. [PMID: 27206310 DOI: 10.1111/liv.13167] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
76 Qi X, Guo X. An early decision of transjugular intrahepatic portosystemic shunt may be considered for non-malignant and non-cirrhotic portal vein thrombosis with ascites: a concise review of the theoretical possibility and practical difficulty. Arch Med Sci 2016;12:1381-3. [PMID: 27904533 DOI: 10.5114/aoms.2016.62921] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
77 Zhang J, Wang Y, Gong J, Zhang F, Zhao Y. Postoperative Anticoagulants in Preventing Portal Vein Thrombosis in Patients Undergoing Splenectomy Because of Liver Cirrhosis: A Meta-Analysis. The American Surgeon 2016;82:1169-77. [DOI: 10.1177/000313481608201222] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
78 Intagliata NM, Ferreira CN, Caldwell SH. Anticoagulación en la trombosis de la vena porta en la cirrosis. Clin Liver Dis (Hoboken) 2016;8:S10-5. [PMID: 31041089 DOI: 10.1002/cld.599] [Reference Citation Analysis]
79 Xue S, Zhang Q, Liu J, Wang PS, Chen G. Diagnosis and treatment of portal vein thrombosis after splenectomy and gastroesophageal devascularization. Shijie Huaren Xiaohua Zazhi 2016; 24(29): 4063-4069 [DOI: 10.11569/wcjd.v24.i29.4063] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
80 Lakhoo J, Gaba RC. Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-mesenterico-portal venous thrombosis. Diagn Interv Imaging. 2016;97:1085-1093. [PMID: 27481577 DOI: 10.1016/j.diii.2016.07.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
81 Qi X, Han G, Ye C, Zhang Y, Dai J, Peng Y, Deng H, Li J, Hou F, Ning Z, Zhao J, Zhang X, Wang R, Guo X. Splenectomy Causes 10-Fold Increased Risk of Portal Venous System Thrombosis in Liver Cirrhosis Patients. Med Sci Monit 2016;22:2528-50. [PMID: 27432511 DOI: 10.12659/msm.898866] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
82 Intagliata NM, Ferreira CN, Caldwell SH. Anticoagulation for portal vein thrombosis in cirrhosis. Clin Liver Dis (Hoboken) 2016;7:126-31. [PMID: 31041046 DOI: 10.1002/cld.552] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
83 Artaza T, Lopes M, Romero M, Sánchez JJ, De la Cruz G, González C, Gómez R. Non-Malignant Portal Vein Thrombosis in Liver Cirrhosis: Diagnosis and Treatment. EMJ Hepatol 2016. [DOI: 10.33590/emjhepatol/10311905] [Reference Citation Analysis]
84 Qi X, He C, Guo W, Yin Z, Wang J, Wang Z, Niu J, Bai M, Yang Z, Fan D, Han G. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with variceal bleeding in liver cirrhosis: outcomes and predictors in a prospective cohort study. Liver Int 2016;36:667-76. [PMID: 26235541 DOI: 10.1111/liv.12929] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 6.0] [Reference Citation Analysis]
85 Chen H, Turon F, Hernández-Gea V, Fuster J, Garcia-Criado A, Barrufet M, Darnell A, Fondevila C, Garcia-Valdecasas JC, Garcia-Pagán JC. Nontumoral portal vein thrombosis in patients awaiting liver transplantation. Liver Transpl 2016;22:352-65. [PMID: 26684272 DOI: 10.1002/lt.24387] [Cited by in Crossref: 77] [Cited by in F6Publishing: 72] [Article Influence: 11.0] [Reference Citation Analysis]
86 Lv Y, He C, Guo W, Yin Z, Wang J, Zhang B, Meng X, Cai J, Luo B, Wu F, Niu J, Fan D, Han G. Transjugular Intrahepatic Portosystemic Shunt for Extrahepatic Portal Venous Obstruction in Children. J Pediatr Gastroenterol Nutr 2016;62:233-41. [PMID: 26381818 DOI: 10.1097/MPG.0000000000000982] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
87 Flanagan E, Ghaderi I, Overby DW, Farrell TM. Reduced Survival in Bariatric Surgery Candidates Delayed or Denied by Lack of Insurance Approval. The American Surgeon 2016;82:166-70. [DOI: 10.1177/000313481608200222] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
88 Sciascia S, Breen K, Hunt BJ. Rivaroxaban use in patients with antiphospholipid syndrome and previous venous thromboembolism. Blood Coagul Fibrinolysis 2015;26:476-7. [PMID: 25923780 DOI: 10.1097/MBC.0000000000000247] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 6.1] [Reference Citation Analysis]
89 Hatzidakis A, Kouroumalis E, Kehagias E, Digenakis E, Samonakis D, Tsetis D. Acute TIPS occlusion due to iatrogenic arteriovenous shunt in a cirrhotic patient with total portal vein thrombosis. Interv Med Appl Sci 2015;7:166-70. [PMID: 26767123 DOI: 10.1556/1646.7.2015.4.6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
90 Chen H, Liu L, Qi X, He C, Wu F, Fan D, Han G. Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis. Eur J Gastroenterol Hepatol 2016;28:82-9. [PMID: 26513611 DOI: 10.1097/MEG.0000000000000482] [Cited by in Crossref: 80] [Cited by in F6Publishing: 84] [Article Influence: 11.4] [Reference Citation Analysis]
91 Bagheri Lankarani K, Homayon K, Motevalli D, Heidari ST, Alavian SM, Malek-Hosseini SA. Risk Factors for Portal Vein Thrombosis in Patients With Cirrhosis Awaiting Liver Transplantation in Shiraz, Iran. Hepat Mon 2015;15:e26407. [PMID: 26977162 DOI: 10.5812/hepatmon.26407] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
92 Li J, Qi X, Deng H, Peng Y, Shao L, Ma J, Sun X, Li H, Guo X. Association of conventional haemostasis and coagulation tests with the risk of acute upper gastrointestinal bleeding in liver cirrhosis: a retrospective study. Gastroenterol Rep (Oxf) 2016;4:315-9. [PMID: 26672007 DOI: 10.1093/gastro/gov059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
93 Dai J, Qi X, Peng Y, Hou Y, Chen J, Li H, Guo X. Association between D-dimer level and portal venous system thrombosis in liver cirrhosis: a retrospective observational study. Int J Clin Exp Med 2015;8:15296-301. [PMID: 26629017] [Reference Citation Analysis]
94 Robertson M, Hayes P. Management of portal hypertension, Budd–Chiari syndrome and portal vein thrombosis. Medicine 2015;43:669-73. [DOI: 10.1016/j.mpmed.2015.08.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
95 Qi X, Guo X, Fan D. Benefit Stratification of Prophylactic Anticoagulation in Liver Cirrhosis: More Questions Than Answers. Clin Gastroenterol Hepatol 2015;13:1856-7. [PMID: 25158923 DOI: 10.1016/j.cgh.2014.08.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
96 Qi X, Li H, Liu X, Yao H, Han G, Hu F, Shao L, Guo X. Novel insights into the development of portal vein thrombosis in cirrhosis patients. Expert Rev Gastroenterol Hepatol 2015;9:1421-32. [PMID: 26325361 DOI: 10.1586/17474124.2015.1083856] [Cited by in Crossref: 21] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
97 Yang S, He C, Fan X, Ding W, Wu X, Li J. Early Prophylactic Anticoagulation via Transjugular Intrahepatic Route for Portal Vein Thrombosis after Splenectomy in Cirrhotic Portal Hypertension. Journal of Vascular and Interventional Radiology 2015;26:1009-17. [DOI: 10.1016/j.jvir.2015.03.008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
98 Tang W, Wang Y, Zhao X, Wang X, Zhang T, Ou X, Shou W, You H, Jia J. Procoagulant imbalance aggravated with falling liver function reserve, but not associated with the presence of portal vein thrombosis in cirrhosis. Eur J Gastroenterol Hepatol 2015;27:672-8. [PMID: 25923942 DOI: 10.1097/MEG.0000000000000352] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
99 Qi X, Su C, Ren W, Yang M, Jia J, Dai J, Xu W, Guo X. Association between portal vein thrombosis and risk of bleeding in liver cirrhosis: A systematic review of the literature. Clin Res Hepatol Gastroenterol 2015;39:683-91. [PMID: 25956490 DOI: 10.1016/j.clinre.2015.02.012] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
100 Dai J, Qi X, Li H, Guo X. Role of D-dimer in the Development of Portal Vein Thrombosis in Liver Cirrhosis: A Meta-analysis. Saudi J Gastroenterol 2015;21:165-74. [PMID: 26021776 DOI: 10.4103/1319-3767.157567] [Cited by in Crossref: 17] [Cited by in F6Publishing: 21] [Article Influence: 2.1] [Reference Citation Analysis]
101 Qi X, Wang Y, Guo X. Portal vein thrombosis significantly improves the survival of cirrhotic patients awaiting liver transplantation: should we accept the statistical results? Eur J Intern Med 2015;26:154-5. [PMID: 25681140 DOI: 10.1016/j.ejim.2015.01.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
102 Qi X, Dai J, Yang M, Ren W, Jia J, Guo X. Association between Portal Vein Thrombosis and Survival in Non-Liver-Transplant Patients with Liver Cirrhosis: A Systematic Review of the Literature. Gastroenterol Res Pract 2015;2015:480842. [PMID: 25810714 DOI: 10.1155/2015/480842] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
103 Basit SA, Stone CD, Gish R. Portal vein thrombosis. Clin Liver Dis 2015;19:199-221. [PMID: 25454305 DOI: 10.1016/j.cld.2014.09.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 35] [Article Influence: 3.4] [Reference Citation Analysis]
104 Qi X, De Stefano V, Li H, Dai J, Guo X, Fan D. Anticoagulation for the treatment of portal vein thrombosis in liver cirrhosis: a systematic review and meta-analysis of observational studies. Eur J Intern Med 2015;26:23-9. [PMID: 25566699 DOI: 10.1016/j.ejim.2014.12.002] [Cited by in Crossref: 104] [Cited by in F6Publishing: 104] [Article Influence: 13.0] [Reference Citation Analysis]
105 Qi X, Yang Z, Fan D. Spontaneous resolution of portal vein thrombosis in cirrhosis: where do we stand, and where will we go? Saudi J Gastroenterol 2014;20:265-6. [PMID: 25253359 DOI: 10.4103/1319-3767.141680] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
106 Qi XS, Bai M, Fan DM. Nonselective β-blockers may induce development of portal vein thrombosis in cirrhosis. World J Gastroenterol 2014;20:11463-6. [PMID: 25170238 DOI: 10.3748/wjg.v20.i32.11463] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 21] [Article Influence: 1.9] [Reference Citation Analysis]